4.5 Article

Psychogenic paroxysmal movement disorders Clinical features and diagnostic clues

期刊

PARKINSONISM & RELATED DISORDERS
卷 20, 期 1, 页码 41-46

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.parkreldis.2013.09.012

关键词

Paroxysmal dyskinesias; Psychogenic movement disorders; PKD; PNKD; PED

资金

  1. Actelion
  2. Ipsen
  3. Pharm Allergan
  4. Merz Pharmaceuticals
  5. Deutsche Forschungsgemeinschaft [MU1692/2-1, SFB 936]
  6. European Science Foundation
  7. Boehringer Ingelheim
  8. Merz pharma companies
  9. Lundbeck
  10. UCB
  11. Abbvie
  12. National Institute for Health Research
  13. GlaxoSmithKline
  14. Orion Corporation
  15. LLC
  16. Halley Stewart Trust through Dystonia Society UK
  17. Wellcome Trust MRC strategic neurodegenerative disease initiative award [WT089698]
  18. Dystonia Coalition
  19. Parkinson's UK [G-1009]
  20. Parkinson&quot
  21. s UK [G-1009] Funding Source: researchfish

向作者/读者索取更多资源

Background: The diagnosis of psychogenic paroxysmal movement disorders (PPMD) can be challenging, in particular their distinction from the primary paroxysmal dyskinesias (PxD) remains difficult. Methods: Here we present a large series of 26 PPMD cases, describe their characteristics, contrast them with primary PxD and focus on their distinguishing diagnostic features. Results: Mean age at onset was 38.6 years, i.e. much later than primary PxD. Women were predominantly affected (73%). Most subjects (88.4%) had long attacks, and unlike primary PxD there was a very high within-subject variability for attack phenomenology, duration and frequency. Dystonia was the most common single movement disorder presentation, but 69.2% of the patients had mixed or complex PxD. In 50% of PPMD cases attack triggers could be identified but these were unusual for primary PxD. 42.3% of patients employed unusual strategies to alleviate or stop the attacks. Response to typical medication used for primary PxD was poor. Precipitation of the disorder due to physical or emotional life events and stressors were documented in 57.6% and 65.3% of the cases respectively. Additional interictal psychogenic signs were documented in 34.6% and further medically unexplained somatic symptoms were present in 50% of the cases. 192% of patients had a comorbid organic movement disorder and 26.9% had preexisting psychiatric comorbidities. Conclusion: Although the phenotypic presentation of PPMD can be highly diverse, certain clinical characteristics help in distinguishing this condition from the primary forms of PxD. Recognition is important as multidisciplinary treatment approaches led to significant improvement in most cases. (C) 2013 The Authors. Published by Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据